• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体4的调控。来自X射线晶体学和分子建模的见解。

Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.

作者信息

Klett Javier, Reeves Jake, Oberhauser Nils, Pérez-Regidor Lucia, Martín-Santamaria Sonsoles

机构信息

Centro de Investigaciones Biologicas, CIB-CSIC. C/ Ramiro de Maeztu, 9. 28040-Madrid, Spain.

出版信息

Curr Top Med Chem. 2014;14(23):2672-83. doi: 10.2174/1568026614666141215144831.

DOI:10.2174/1568026614666141215144831
PMID:25515751
Abstract

Toll-like receptors (TLRs) are a family of proteins with a key role in the innate immune system. They are specialized in the recognition of molecular patterns present in microbial components, through mechanisms not yet unraveled at atomic level. Improvement in the understanding of the molecular mechanisms that drive TLR signaling is of paramount importance to grasp key aspects of immunity, potentially leading to the design of new molecules able to modulate their functions. Toll-like receptor 4 (TLR4), along with its accessory protein myeloid differentiation factor 2 (MD-2), builds a heterodimeric complex that specifically recognizes lipopolysaccharides (LPS), which are present on the cell wall of gramnegative bacteria, activating the immune response. Some TLR4 modulators are undergoing preclinical and clinical evaluation for the treatment of sepsis, inflammatory diseases, cancer, and rheumatoid arthritis. Reported X-ray crystal structures together with molecular modeling studies, not reviewed before in the literature, have recently contributed to the elucidation of key interactions at atomic level of the binding between the TLR4/MD-2 system and different TLR4/MD-2 ligands. The purpose of this review is to summarize these reported studies which may account for the SAR rationalization of natural/ synthetic agonist/antagonist TLR4 binders and may also guide further design of novel TLR4 modulators.

摘要

Toll样受体(TLRs)是一类在先天免疫系统中起关键作用的蛋白质家族。它们专门通过尚未在原子水平上阐明的机制识别微生物成分中存在的分子模式。深入了解驱动TLR信号传导的分子机制对于掌握免疫的关键方面至关重要,这可能会促使设计出能够调节其功能的新分子。Toll样受体4(TLR4)与其辅助蛋白髓样分化因子2(MD-2)形成异二聚体复合物,该复合物特异性识别存在于革兰氏阴性菌细胞壁上的脂多糖(LPS),从而激活免疫反应。一些TLR4调节剂正在进行治疗败血症、炎症性疾病、癌症和类风湿性关节炎的临床前和临床评估。已报道的X射线晶体结构以及文献中之前未综述过的分子建模研究,最近有助于阐明TLR4/MD-2系统与不同TLR4/MD-2配体之间结合在原子水平上的关键相互作用。本综述的目的是总结这些已报道的研究,这些研究可能有助于对天然/合成激动剂/拮抗剂TLR4结合剂进行构效关系合理化分析,也可能指导新型TLR4调节剂的进一步设计。

相似文献

1
Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.Toll样受体4的调控。来自X射线晶体学和分子建模的见解。
Curr Top Med Chem. 2014;14(23):2672-83. doi: 10.2174/1568026614666141215144831.
2
Computational Approaches to Toll-Like Receptor 4 Modulation.Toll样受体4调控的计算方法
Molecules. 2016 Jul 30;21(8):994. doi: 10.3390/molecules21080994.
3
Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.基于药效团的结构见解,通过计算机辅助筛选,鉴定人源 Toll 样受体 4-髓样分化因子 2(hTLR4-MD-2)复合物抑制剂。
J Biomol Struct Dyn. 2019 May;37(8):1968-1991. doi: 10.1080/07391102.2018.1474804. Epub 2018 May 29.
4
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.TLR4-MD-2复合物识别脂多糖的结构基础。
Nature. 2009 Apr 30;458(7242):1191-5. doi: 10.1038/nature07830. Epub 2009 Mar 1.
5
Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.念珠藻毒素变体和磷酸化衍生物通过Toll样受体4/髓样分化因子2复合物促进先天免疫反应。
J Biol Chem. 2017 Sep 15;292(37):15378-15394. doi: 10.1074/jbc.M117.791780. Epub 2017 Jul 28.
6
Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.用二糖脂质 A 类似物定制调节细胞促炎反应。
Front Immunol. 2021 Mar 18;12:631797. doi: 10.3389/fimmu.2021.631797. eCollection 2021.
7
Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.利用酵母展示和突变分析对TLR4相关蛋白MD-2进行的研究。
Mol Immunol. 2015 Dec;68(2 Pt A):203-12. doi: 10.1016/j.molimm.2015.08.008. Epub 2015 Aug 28.
8
Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.部分糖基化树突状聚合物可阻断 MD-2 并抑制 TLR4-MD-2-LPS 复合物介导的细胞因子反应。
PLoS Comput Biol. 2011 Jun;7(6):e1002095. doi: 10.1371/journal.pcbi.1002095. Epub 2011 Jun 30.
9
Two modes of ligand recognition by TLRs.Toll样受体识别配体的两种模式。
Cell. 2007 Sep 21;130(6):979-81. doi: 10.1016/j.cell.2007.09.009.
10
The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex.MD-2/TLR4受体复合物对脂多糖进行物种特异性识别的分子机制。
Mol Immunol. 2015 Feb;63(2):134-42. doi: 10.1016/j.molimm.2014.06.034. Epub 2014 Jul 15.

引用本文的文献

1
Molecular insights into pangenome localization and constructs design for Hemophilus influenza vaccine.流感嗜血杆菌疫苗全基因组定位及构建设计的分子见解
Sci Rep. 2025 Jul 1;15(1):22316. doi: 10.1038/s41598-025-03536-0.
2
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0".特刊:“Toll 样受体(TLRs)在感染和炎症中的作用 2.0”
Int J Mol Sci. 2024 Sep 7;25(17):9709. doi: 10.3390/ijms25179709.
3
Small Molecules as Toll-like Receptor 4 Modulators Drug and Computational Repurposing.作为Toll样受体4调节剂的小分子:药物与计算性重新利用
Biomedicines. 2022 Sep 19;10(9):2326. doi: 10.3390/biomedicines10092326.
4
Full-Atom Model of the Agonist LPS-Bound Toll-like Receptor 4 Dimer in a Membrane Environment.激动剂 LPS 结合的 Toll 样受体 4 二聚体在膜环境中的全原子模型。
Chemistry. 2021 Nov 5;27(62):15406-15425. doi: 10.1002/chem.202102995. Epub 2021 Oct 12.
5
Identification of a Heme Activation Site on the MD-2/TLR4 Complex.鉴定 MD-2/TLR4 复合物上的血红素激活位点。
Front Immunol. 2020 Jun 30;11:1370. doi: 10.3389/fimmu.2020.01370. eCollection 2020.
6
Piperidylmethyloxychalcone improves immune-mediated acute liver failure via inhibiting TAK1 activity.哌啶基甲氧基查尔酮通过抑制 TAK1 活性改善免疫介导的急性肝衰竭。
Exp Mol Med. 2017 Nov 17;49(11):e392. doi: 10.1038/emm.2017.156.
7
Brucella Lipopolysaccharide and pathogenicity: The core of the matter.布鲁氏菌脂多糖与致病性:问题的核心
Virulence. 2018 Jan 1;9(1):379-382. doi: 10.1080/21505594.2017.1395544.
8
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.TLR4信号通路调节剂作为炎症和脓毒症的潜在治疗药物
Vaccines (Basel). 2017 Oct 4;5(4):34. doi: 10.3390/vaccines5040034.
9
Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators.用于发现Toll样受体调节剂的虚拟筛选方法
Int J Mol Sci. 2016 Sep 9;17(9):1508. doi: 10.3390/ijms17091508.
10
Computational Approaches to Toll-Like Receptor 4 Modulation.Toll样受体4调控的计算方法
Molecules. 2016 Jul 30;21(8):994. doi: 10.3390/molecules21080994.